Document is current
Any future updates will be listed below
-
Authors
Zhang, Xuefei
Zheng, Wei
Li, Haixia
Zhang, Lei
Zhao, Haidong
Sui, Shiyao
Cheng, Wen
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82003067, 81873900)
Heilongjiang Provincial Postdoctoral Science Foundation (LBH-Z20080)
Postdoctoral Science Foundation of China (2021M693827)
Outstanding Project of Haiyan Fund of Harbin Medical University Cancer Hospital (JJZD2021-12)
Top young talent program of Harbin Medical University Cancer Hospital (BJQN2021-04)
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 28 July 2025
First Online: 4 August 2025
Declarations
:
: The studies involving human cell lines and rats were reviewed and approved by Harbin Medical University (Ethical approval number: KY2022-23). The human cancer cell lines were purchased from Institution of Procell Life Science &Technology (China) and Institution of OTWO Biotech (China).
: The authors declare no competing interests.
